Celltrion Pharm, Inc.
Clinical trials sponsored by Celltrion Pharm, Inc., explained in plain language.
-
One pill to tackle two heart risks: new combo therapy tested
Disease control CompletedThis completed Phase 3 trial tested whether a single pill combining ezetimibe, rosuvastatin, and amlodipine can safely lower both cholesterol and blood pressure in 163 Korean adults with hypertension and high cholesterol. Participants took the combination pill or a control for 8 …
Phase: PHASE3 • Sponsor: Celltrion Pharm, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Diabetes drug showdown: which Add-On works best?
Disease control CompletedThis study tested whether adding pioglitazone or dapagliflozin to standard diabetes pills (alogliptin and metformin) helps control blood sugar better in adults with type 2 diabetes. A total of 133 participants took one of the two extra drugs for 26 weeks. The main goal was to see…
Phase: PHASE4 • Sponsor: Celltrion Pharm, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC